Arrhythmias & electrophysiology

Disturbed atrial metabolism, shear stress, and cardiac load contribute to atrial fibrillation after ablation: AXAFA biomolecule study

EuropacePublished Secondary analysis of the AXAFA randomised trial

Authors' conclusion

Elevated concentrations of ANGPT2, BMP10, and NT-proBNP are associated with recurrent AF after a first AF ablation, suggesting that processes linked to disturbed cardiomyocyte metabolism, altered atrial shear stress, and increased load contribute to AF after AF ablation in patients.

Study context

Population
Patients undergoing a first atrial fibrillation (AF) ablation (64 years [58, 70]; 33% women)
Participants
433 patients
Comparison
Baseline circulating biomolecule concentrations, recurrent AF vs no recurrence
  • Recurrent AFn = 120
Primary endpoint
Recurrent AF
Follow-up
First 3 months after AF ablation
Methodological detailsbiomolecule study, 12 circulating biomolecules quantified in plasma before first AF ablation; Cox regression
  • Biomolecule study
  • 12 circulating biomolecules quantified in plasma before first AF ablation; Cox regression

Primary result

As reported in the abstract

Recurrent AF, adjusted for 11 clinical features and randomized treatment
Hazard ratio (95% CI)
Elevated NT-proBNP
1.58(1.29–1.94)
Elevated ANGPT2
1.37(1.12–1.67)
Elevated BMP10
1.24(1.02–1.51)

Further findings

Change in biomolecule concentrations

ANGPT2, BMP10 and NT-proBNP decreased in arrhythmia-free patients but not in patients with recurrent AF
Other eight biomarkers unchanged

Original publication

Disturbed atrial metabolism, shear stress, and cardiac load contribute to atrial fibrillation after ablation: AXAFA biomolecule study. Europace. Published 24 January 2024. doi:10.1093/europace/euae028

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.